In the present study, the role of TAS2R8 and TAS2R10 in the stemness of the NB cancer cells examined suggests their potential as chemotherapeutic targets, despite previously characterizations of TAS2Rs as elusive receptors with distinct signaling pathway and functions compared with other GPCRs. The gene discussed is TAS2R10; the disease is cancer.